Forbes -
17 Aug 2015 19:41
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.9% on the day. Components of that ETF showing particular strength include shares of Karyopharm Therapeutics (KPTI), up about 18% and shares of Esperion Therapeutics (ESPR), up about 13% on the day.
Share this Article